Security National Bank of Sioux City Iowa IA Purchases 1,560 Shares of Thermo Fisher Scientific Inc. $TMO

Security National Bank of Sioux City Iowa IA grew its position in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 25.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,783 shares of the medical research company's stock after acquiring an additional 1,560 shares during the quarter. Thermo Fisher Scientific accounts for 1.6% of Security National Bank of Sioux City Iowa IA's portfolio, making the stock its 16th biggest holding. Security National Bank of Sioux City Iowa IA's holdings in Thermo Fisher Scientific were worth $3,902,000 at the end of the most recent quarter.

• The Market Is Selling Everything, but These 5 Stocks Aren't Breaking Down

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Kilter Group LLC purchased a new stake in Thermo Fisher Scientific during the second quarter valued at $25,000. Legacy Wealth Managment LLC ID increased its holdings in shares of Thermo Fisher Scientific by 78.6% in the 1st quarter. Legacy Wealth Managment LLC ID now owns 50 shares of the medical research company's stock worth $25,000 after buying an additional 22 shares during the last quarter. Core Wealth Advisors LLC purchased a new stake in shares of Thermo Fisher Scientific during the 4th quarter valued at about $30,000. Allied Private Wealth LLC bought a new position in shares of Thermo Fisher Scientific in the 2nd quarter valued at about $26,000. Finally, MBM Wealth Consultants LLC purchased a new position in Thermo Fisher Scientific in the first quarter worth about $29,000. 89.23% of the stock is currently owned by institutional investors.

Insider Activity

In related news, COO Gianluca Pettiti sold 400 shares of the company's stock in a transaction on Monday, July 27th. The stock was sold at an average price of $565.00, for a total value of $226,000.00. Following the transaction, the chief operating officer directly owned 24,651 shares of the company's stock, valued at $13,927,815. This represents a 1.60% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Lisa P. Britt sold 11,440 shares of the business's stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $613.12, for a total value of $7,014,092.80. Following the sale, the vice president owned 14,784 shares in the company, valued at approximately $9,064,366.08. The trade was a 43.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 73,768 shares of company stock valued at $44,122,820. 0.33% of the stock is currently owned by corporate insiders.

Thermo Fisher Scientific Trading Down 1.1%

• The Often-Missed Corner of Healthcare That Wall Street Is Loving

Shares of NYSE:TMO traded down $7.50 during trading on Friday, reaching $650.82. 4,579,493 shares of the company were exchanged, compared to its average volume of 2,260,237. The business's fifty day simple moving average is $590.31 and its 200-day simple moving average is $522.03. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.55 and a quick ratio of 1.18. Thermo Fisher Scientific Inc. has a 12-month low of $435.27 and a 12-month high of $663.57. The firm has a market capitalization of $240.64 billion, a PE ratio of 35.01, a P/E/G ratio of 2.71 and a beta of 0.85.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings data on Thursday, July 23rd. The medical research company reported $6.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.71 by $0.32. Thermo Fisher Scientific had a return on equity of 17.09% and a net margin of 15.04%.The company had revenue of $11.99 billion for the quarter, compared to analysts' expectations of $11.71 billion. During the same quarter in the prior year, the firm earned $4.28 earnings per share. Thermo Fisher Scientific's revenue was up 10.5% compared to the same quarter last year. Thermo Fisher Scientific has set its FY 2026 guidance at 24.930-25.330 EPS. On average, research analysts anticipate that Thermo Fisher Scientific Inc. will post 25.13 EPS for the current year.

Thermo Fisher Scientific Dividend Announcement

• Sector Rotation: 2 Smart Money Moves for 2026

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be given a dividend of $0.47 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.88 dividend on an annualized basis and a yield of 0.3%. Thermo Fisher Scientific's dividend payout ratio (DPR) is 10.11%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Evercore set a $570.00 price objective on Thermo Fisher Scientific in a research note on Monday, July 6th. UBS Group raised Thermo Fisher Scientific from a "neutral" rating to a "buy" rating and boosted their target price for the company from $540.00 to $730.00 in a research report on Tuesday, September 8th. Citigroup downgraded Thermo Fisher Scientific from a "buy" rating to an "underperform" rating in a research report on Wednesday, September 9th. Morgan Stanley boosted their price objective on shares of Thermo Fisher Scientific from $620.00 to $650.00 and gave the company an "overweight" rating in a research report on Friday, July 24th. Finally, Royal Bank Of Canada increased their target price on shares of Thermo Fisher Scientific from $490.00 to $580.00 and gave the company a "sector perform" rating in a research note on Friday, July 24th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $624.64.

Check Out Our Latest Stock Report on TMO

Thermo Fisher Scientific Company Profile

(Free Report)

Thermo Fisher Scientific Inc is a global supplier of scientific equipment, laboratory services and analytical technologies. The company serves pharmaceutical and biotechnology companies, clinical laboratories, academic and government institutions, industrial businesses and other research organizations.

Its products and services include laboratory instruments, analytical systems, reagents, consumables, software and related services. Thermo Fisher also provides laboratory supplies and equipment, bioproduction solutions, genetic analysis technologies, clinical diagnostics, specialty diagnostic products and contract research and manufacturing services through its laboratory services businesses.

The company was formed in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific International.

Further Reading

• Five stocks we like better than Thermo Fisher Scientific
• J.B. Hunt's Stock Plunges After Market Misprices Profit Warning
• 2 Stocks Breaking Out Post-FOMC With One Thing in Common
• Lennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
• These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Thermo Fisher Scientific Right Now?

Before you consider Thermo Fisher Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.

While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here